1. The effect and mechanism of action of metformin on in vitro FaDu cell proliferation
    Ruijie Sun et al, 2016, J Int Med Res CrossRef
  2. Inhibitory effect of Ginkgol C17:1 on the biological behavior of tumor cells.
    Yueying Li et al, 2017, Oncol Lett CrossRef
  3. Anti-tumoral effects of exercise on hepatocellular carcinoma growth
    Uttara Saran et al, 2018, Hepatology Communications CrossRef
  4. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
    Mei Peng et al, 2017, Cancer Treatment Reviews CrossRef
  5. A unified mitochondria mechanistic target of rapamycin acyl-coenzyme A dehydrogenase 10 signal relay modulation for metformin growth inhibition in human immortalized keratinocytes cells
    Jiawen Wu et al, 2018, J Cell Biochem CrossRef
  6. Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
    Zahra Nozhat et al, 2018, DARU J Pharm Sci CrossRef
  7. The Influence of Metformin on Age-Related Changes in the Number and Proliferation of Dermal Fibroblasts in Mice
    A. G. Gunin et al, 2019, Adv Gerontol CrossRef
  8. In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications
    Oshra Betzer et al, 2015, Sci Rep CrossRef
  9. Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy
    Fangfang Wang et al, 2015, Leukemia Research CrossRef
  10. A novel Hericium erinaceus polysaccharide: structural characterization and prevention of H2O2-induced oxidative damage in GES-1 cells
    Bingwu Liao et al, 2019, International Journal of Biological Macromolecules CrossRef
  11. Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
    Choudhary Harsha et al, 2020, IJMS CrossRef
  12. Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells
    Vineela Chukkapalli et al, 2018, Oncotarget CrossRef
  13. MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway
    Yuan Qu et al, 2016, Oncotarget CrossRef
  14. MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
    Junwoo Lee et al, 2019, Int J Oncol CrossRef
  15. Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway
    Yindi He et al, 2017, Oncol Lett CrossRef
  16. The co‑treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells
    Zhaodi Zheng et al, 2018, Oncol Lett CrossRef
  17. Metformin attenuates hypoxia‑induced resistance to cisplatin in the HepG2 cell line
    Hiromasa Fujita et al, 2018, Oncol Lett CrossRef
  18. Postnatal metformin treatment alters rat Sertoli cell proliferation and daily sperm production
    Gustavo Marcelo Rindone et al, 2021, Andrology CrossRef
  19. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line
    Carsten Lange et al, 2021, PLoS ONE CrossRef
  20. FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance
    Zhijie Wang et al, 2021, J. Med. Chem. CrossRef
  21. Developing an analytical method by HPLC for simultaneous quantification of methylene blue and metformin applied to in vitro skin permeation and retention studies
    Lisa Carvalho Matos et al, 2021, Biomedical Chromatography CrossRef
  22. The Effect of Astaxanthin and Metformin on Oxidative Stress in Granulosa Cells of BALB C Mouse Model of Polycystic Ovary Syndrome
    Fatemeh Ebrahimi et al, 2021, Reprod. Sci. CrossRef
  23. Metformin Potentiates the Anticancer Effect of Everolimus on Cervical Cancer In Vitro and In Vivo.
    Ya-Hui Chen et al, 2021, Cancers (Basel) CrossRef
  24. Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy
    Éva Remenár et al, 2022, JCO Precision Oncology CrossRef
  25. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway
    Xinyan Huang et al, 2022, Tissue and Cell CrossRef
  26. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line
    Zahra Nozhat et al, 2022, ACAMC CrossRef
  27. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy
    Chunyan Hu et al, 2022, Pathology - Research and Practice CrossRef
  28. Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
    Larissa Gabriella Fusco Donadon et al, 2023, International Journal of Pharmaceutics CrossRef
  29. Regulatory Basis of Adipokines Leptin and Adiponectin in Epilepsy: from Signaling Pathways to Glucose Metabolism
    Yisi Shan et al, 2023, Neurochem Res CrossRef